MAIA Biotechnology (MAIA) Net Shares Issued and Repurchased (2022 - 2026)

MAIA Biotechnology (MAIA) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $641089.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 43.54% year-over-year to $641089.0 in Q1 2026; TTM through Mar 2026 was $641089.0, a 43.54% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, up 32.06% from the prior year.
• Net Shares Issued and Repurchased was $641089.0 for Q1 2026 at MAIA Biotechnology, down from $4.0 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $4.0 million in Q4 2025 and troughed at $641089.0 in Q1 2026.
• A 5-year average of $1.6 million and a median of $1.1 million in 2024 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased soared 97.95% in 2023 and tumbled 43.54% in 2026, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $811831.0 in 2022, then soared by 97.95% to $1.6 million in 2023, then soared by 89.41% to $3.0 million in 2024, then jumped by 32.06% to $4.0 million in 2025, then plunged by 84.05% to $641089.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $641089.0 (Q1 2026), $4.0 million (Q4 2025), and $1.1 million (Q1 2025), per Business Quant data.